Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.
2.

Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit.

Rothberg MB, Celestin C, Fiore LD, Lawler E, Cook JR.

Ann Intern Med. 2005 Aug 16;143(4):241-50.

PMID:
16103468
3.
4.
5.

Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients.

Andreotti F, Testa L, Biondi-Zoccai GG, Crea F.

Eur Heart J. 2006 Mar;27(5):519-26. Epub 2005 Sep 5. Review.

PMID:
16143706
6.
7.

Effect of fixed low-dose warfarin added to aspirin in the long term after acute myocardial infarction; the LoWASA Study.

Herlitz J, Holm J, Peterson M, Karlson BW, Haglid Evander M, Erhardt L; LoWASA study group.

Eur Heart J. 2004 Feb;25(3):232-9.

PMID:
14972424
8.

Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.

Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL; SPORTIF Investigators.

Am Heart J. 2006 Nov;152(5):967-73.

PMID:
17070169
9.

Adjusted indirect meta-analysis of aspirin plus warfarin at international normalized ratios 2 to 3 versus aspirin plus clopidogrel after acute coronary syndromes.

Testa L, Zoccai GB, Porto I, Trotta G, Agostoni P, Andreotti F, Crea F.

Am J Cardiol. 2007 Jun 15;99(12):1637-42. Epub 2007 Apr 27.

PMID:
17560866
10.

Occult bleeding in three different antithrombotic regimes after myocardial infarction. A WARIS-II subgroup analysis.

Hurlen M, Eikvar L, Seljeflot I, Arnesen H.

Thromb Res. 2006;118(4):433-8. Epub 2005 Aug 31.

PMID:
16139331
11.

Aspirin and warfarin versus aspirin monotherapy after myocardial infarction.

Jeddy AS, Gleason BL.

Ann Pharmacother. 2003 Oct;37(10):1502-5. Review.

PMID:
14519047
12.

Influence of aspirin on inflammatory markers in patients after acute myocardial infarction.

Solheim S, Arnesen H, Eikvar L, Hurlen M, Seljeflot I.

Am J Cardiol. 2003 Oct 1;92(7):843-5.

PMID:
14516890
13.

Less benefit from warfarin in diabetics after myocardial infarction?

Smith PJ, Hurlen M, Abdelnoor M, Arnesen H.

Cardiology. 2008;111(3):161-6. doi: 10.1159/000121598. Epub 2008 Apr 25.

PMID:
18434719
14.

Combination antithrombotic therapy with antiplatelet agents and anticoagulants for patients with atherosclerotic heart disease.

Arjomand H, Cohen M, Ezekowitz MD.

J Invasive Cardiol. 2004 May;16(5):271-8. Review.

PMID:
15152137
15.

[Secondary prevention after acute myocardial infarction: aspirin, warfarin or both?].

Reikvam A, Madsen S, Landmark K.

Tidsskr Nor Laegeforen. 2003 Jun 26;123(13-14):1838-40. Review. Norwegian.

PMID:
12830258
16.
17.

Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation.

Orford JL, Fasseas P, Melby S, Burger K, Steinhubl SR, Holmes DR, Berger PB.

Am Heart J. 2004 Mar;147(3):463-7.

PMID:
14999195
18.

Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy.

Berger JS, Stebbins A, Granger CB, Ohman EM, Armstrong PW, Van de Werf F, White HD, Simes RJ, Harrington RA, Califf RM, Peterson ED.

Circulation. 2008 Jan 15;117(2):192-9. Epub 2007 Dec 17.

19.

Bleeding complications in skin cancer surgery are associated with warfarin but not aspirin therapy.

Dixon AJ, Dixon MP, Dixon JB.

Br J Surg. 2007 Nov;94(11):1356-60.

PMID:
17654609
20.

Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding.

Wang TY, Xiao L, Alexander KP, Rao SV, Kosiborod MN, Rumsfeld JS, Spertus JA, Peterson ED.

Circulation. 2008 Nov 18;118(21):2139-45. doi: 10.1161/CIRCULATIONAHA.108.787143. Epub 2008 Nov 3.

Supplemental Content

Support Center